Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes

Launched by IRXREMINDER · Aug 21, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to monitor a condition called Tardive Dyskinesia (TD), which causes involuntary movements, often in people who take certain psychiatric medications. The goal is to see if remote assessments—like video calls or online questionnaires—can help doctors better understand and track TD symptoms, ultimately improving patient care.

If you or a family member are between the ages of 65 and 74 and have been taking an antipsychotic medication for at least 90 days, you may be eligible to participate. It’s important that you don't have TD symptoms caused by conditions like Parkinson's disease or Tourette's syndrome, and you should be able to communicate in English. Participants will engage in remote evaluations and provide feedback on their symptoms. This study is currently recruiting, and your involvement could help advance the understanding and treatment of Tardive Dyskinesia for others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• For the non-TD group:
• • 1. Prescribed and taking an antipsychotic medication for 90-days or longer.
• • 2. Tardive Dyskinesia symptoms if present are not from Parkinsons, Tourette's syndrome, Huntington disease.
• • 3. Signed an informed consent.
• • 4. Speaks English fluently.
• Exclusion Criteria:
• • 1. Suffered a moderate or severe head injury in the last year;
• • 2. History of a learning disorder or developmental disability that would inhibit a patient from completing the TD protocol.
• • 3. Severe visual impairment that is cannot be corrected by glasses or contacts.